Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients With Premorbid Disability or Dementia
Published: March 28, 2022
![Two paramedics putting senior woman into ambulance.](/-/media/PHD-Images/Science-News/p/paramedics_putting_senior_woman_into_ambulance.jpg?h=343&iar=0&mh=515&mw=515&w=515)
- Patients with pre-morbid disability or dementia have historically been excluded from stroke clinical trials for reperfusion therapy or for endovascular treatment.
- These patients present a dilemma for the treating clinician faced with making decisions for the care of this special group of patients.
- This scientific statement proposes principles for clinicians and clinician-scientists on how to approach caring for patients with pre-morbid disability or dementia.
Supporting Materials
- Commentary: The Knowns and the Unknowns of Acute Ischemic Stroke Treatments for Patients With Pre-existing Disability and Dementia by Eva A. Mistry, MBBS, MSCI, FAHA
- Top Things to Know: Endovascular Treatment and Thrombolysis for Acute Ischemic Stroke in Patients With Premorbid Disability or Dementia
- Slide Set (PDF)
- News Release: Stroke treatments safe and effective for people with existing disability or dementia
Recommended Reading
- Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke
- 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
- Heart and Stroke Stats 2022
- Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke